Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Heartseed to initiate phase I/II LAPiS study of iPSC-derived cardiomyocyte spheroids

March 26, 2021

Microvesicles promote infarct recovery in primates

March 25, 2021

ARTham Therapeutics provides first phase I data for ART-001 in healthy volunteers

March 22, 2021

FDA approves Arcalyst for recurrent pericarditis

March 19, 2021

Hefei Institutes of Physical Sciences presents new PDGFR-alpha and/or PDGFR-beta inhibitors

March 18, 2021

Injectable hydrogel with MSN/microRNA-21-5p complexes reduces infarct size in vivo

March 11, 2021

SBI and University of Oxford initiate phase II study of cardioprotective agent using 5-ALA

March 9, 2021

MicroRNA switch therapy self-assembles into nanoparticles to treat atherosclerosis

Feb. 26, 2021

Longeveron completes phase I study of Lomecel-B in hypoplastic left heart syndrome

Feb. 25, 2021

FDA approves label expansion in chronic heart failure for Entresto

Feb. 17, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...